NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease

por Michelotti, Anna, de Scordilli, Marco, Bertoli, Elisa, De Carlo, Elisa, Del Conte, Alessandro, Bearz, Alessandra
Publicado 2022

Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials

por de Scordilli, Marco, Michelotti, Anna, Bertoli, Elisa, De Carlo, Elisa, Del Conte, Alessandro, Bearz, Alessandra
Publicado 2022

Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer

por Stanzione, Brigida, Del Conte, Alessandro, Bertoli, Elisa, De Carlo, Elisa, Revelant, Alberto, Spina, Michele, Bearz, Alessandra
Publicado 2023

Can Work Engagement Be a Resource for Reducing Workaholism’s Undesirable Outcomes? A Multiple Mediating Model Including Moderated Mediation Analysis

por Scafuri Kovalchuk, Liliya, Buono, Carmela, Ingusci, Emanuela, Maiorano, Francesco, De Carlo, Elisa, Madaro, Andreina, Spagnoli, Paola
Publicado 2019

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era

por De Carlo, Elisa, Bertoli, Elisa, Del Conte, Alessandro, Stanzione, Brigida, Berto, Eleonora, Revelant, Alberto, Spina, Michele, Bearz, Alessandra
Publicado 2022

Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications

por Del Conte, Alessandro, De Carlo, Elisa, Bertoli, Elisa, Stanzione, Brigida, Revelant, Alberto, Bertola, Manuela, Spina, Michele, Bearz, Alessandra
Publicado 2022

Acquired Resistance to Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?

por Bertoli, Elisa, De Carlo, Elisa, Del Conte, Alessandro, Stanzione, Brigida, Revelant, Alberto, Fassetta, Kelly, Spina, Michele, Bearz, Alessandra
Publicado 2022

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications

por Bertoli, Elisa, De Carlo, Elisa, Basile, Debora, Zara, Diego, Stanzione, Brigida, Schiappacassi, Monica, Del Conte, Alessandro, Spina, Michele, Bearz, Alessandra
Publicado 2023

Chemotherapy prescribing errors: an observational study on the role of information technology and computerized physician order entry systems

por Aita, Marianna, Belvedere, Ornella, De Carlo, Elisa, Deroma, Laura, De Pauli, Federica, Gurrieri, Lorena, Denaro, Angela, Zanier, Loris, Fasola, Gianpiero
Publicado 2013

The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation

por Bearz, Alessandra, De Carlo, Elisa, Del Conte, Alessandro, Spina, Michele, Da Ros, Valentina, Bertoli, Elisa, Revelant, Alberto, Stanzione, Brigida, Tirelli, Umberto
Publicado 2022

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience

por De Carlo, Elisa, Del Savio, Maria Chiara, Polesel, Jerry, Da Ros, Valentina, Berto, Eleonora, Santarossa, Sandra, Chimienti, Emanuela, Fratino, Lucia, Bearz, Alessandra
Publicado 2018

Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case report

por De Carlo, Elisa, Schiappacassi, Monica, Urbani, Martina, Doliana, Roberto, Baldassarre, Gustavo, Da Ros, Valentina, Santarossa, Sandra, Chimienti, Emanuela, Berto, Eleonora, Fratino, Lucia, Bearz, Alessandra
Publicado 2018